ACTA1 and Peritoneal Fibrosis: Arai et al (17) demonstrated that thalidomide was able to reduce the levels of the vascular endothelial growth factor, TGF-β1 and α-SMA to prevent the occurrence of peritoneal fibrosis in rats.